Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB vs NITRENDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB vs NITRENDIPINE: Safety Overview

Metric NIRSEVIMAB NITRENDIPINE
Total FAERS Reports 247 353
Deaths Reported 5 13
Death Rate 2.0% 3.7%
Hospitalizations 149 243
Average Patient Age 0.3 yrs 70.9 yrs
% Female Patients 42.3% 41.9%
Manufacturer Sanofi Pasteur Inc. N/A
Route INTRAMUSCULAR N/A